Risk, Protective, and Biomarkers of Dementia in Indigenous Peoples: A Systematic Review

Overview

Journal Alzheimers Dement

Specialties Neurology
Psychiatry

Date 2023 Sep 25

PMID 37746888

Authors

Huong X T Nguyen

Kate Bradley

Bridgette J McNamara

Rosie Watson

Roslyn Malay

Dina LoGiudice

Affiliations

Soon will be listed here.

Abstract

Introduction: Dementia is an emergent health priority for Indigenous peoples worldwide, yet little is known about disease drivers and protective factors.

Methods: Database searches were conducted in March 2022 to identify original publications on risk, protective, genetic, neuroradiological, and biological factors related to dementia and cognitive impairment involving Indigenous peoples.

Results: Modifiable risk factors featured across multiple studies include childhood adversity, hearing loss, low education attainment, unskilled work history, stroke, head injury, epilepsy, diabetes, hypertension, hyperlipidemia, depression, low BMI, poor mobility, and continence issues. Non-modifiable risk factors included increasing age, sex, and genetic polymorphisms. Education, ex-smoking, physical and social activity, and engagement with cultural or religious practices were highlighted as potential protective factors. There is a paucity of research on dementia biomarkers involving Indigenous peoples.

Discussion: Greater understanding of modifiable factors and biomarkers of dementia can assist in strength-based models to promote healthy ageing and cognition for Indigenous peoples.

Citing Articles

Detection of cognitive impairment, dementia and associated risk factors among Aboriginal and Torres Strait Islander peoples: Retrospective baseline audit results from a stepped-wedge cluster-randomised controlled trial.

Bradley K, Hughson J, Hyde Z, Atkinson D, Russell S, Quigley R Australas J Ageing. 2025; 44(1):e70007.

PMID: 40044610 PMC: 11882482. DOI: 10.1111/ajag.70007.

Culturally safe and ethical biomarker and genomic research with Indigenous peoples-a scoping review.

Pra R, OBrien P, Nguyen H, Luke J, Smith R, Withall A BMC Glob Public Health. 2024; 2(1):72.

PMID: 39681973 PMC: 11622903. DOI: 10.1186/s44263-024-00102-0.

Dementia diagnostic and treatment services in the Western Pacific: challenges, preparedness and opportunities in the face of amyloid-targeting therapies.

OCallaghan C, Michaelian J, Aihara Y, Anlacan V, Chen C, Cheung G Lancet Reg Health West Pac. 2024; 50:101183.

PMID: 39399864 PMC: 11471058. DOI: 10.1016/j.lanwpc.2024.101183.

Prevalence and risk factors for Alzheimer's disease and related dementias in Ghana: Evidence from a cross-sectional population-based study.

Paul O, Appiah-Brempong E, Singh A, Qanungo S, Donkor P, Mock C Cogent Public Health. 2024; 11(1).

PMID: 39049873 PMC: 11263803. DOI: 10.1080/27707571.2024.2354393.

Epidemiology and prevalence of dementia and Alzheimer's disease in American Indians: Data from the Strong Heart Study.

Suchy-Dicey A, Domoto-Reilly K, Nelson L, Jayadev S, Buchwald D, Grabowski T Alzheimers Dement. 2024; 20(6):4174-4184.

PMID: 38747387 PMC: 11180871. DOI: 10.1002/alz.13849.

References

Sundar P, Yu C, Sieh W, Steinbart E, Garruto R, Oyanagi K . Two sites in the MAPT region confer genetic risk for Guam ALS/PDC and dementia. Hum Mol Genet. 2006; 16(3):295-306. DOI: 10.1093/hmg/ddl463. View

Smith M, Van N, Roberts A, Hosaka K, Choi S, Viereck J . Disparities in Alzheimer Disease and Mild Cognitive Impairment Among Native Hawaiians and Pacific Islanders. Cogn Behav Neurol. 2021; 34(3):200-206. PMC: 8425603. DOI: 10.1097/WNN.0000000000000279. View

Hendrie H, Hall K, Pillay N, Rodgers D, Prince C, Norton J . Alzheimer's disease is rare in Cree. Int Psychogeriatr. 1993; 5(1):5-14. DOI: 10.1017/s1041610293001358. View

Huria T, Palmer S, Pitama S, Beckert L, Lacey C, Ewen S . Consolidated criteria for strengthening reporting of health research involving indigenous peoples: the CONSIDER statement. BMC Med Res Methodol. 2019; 19(1):173. PMC: 6688310. DOI: 10.1186/s12874-019-0815-8. View

Harfield S, Pearson O, Morey K, Kite E, Canuto K, Glover K . Assessing the quality of health research from an Indigenous perspective: the Aboriginal and Torres Strait Islander quality appraisal tool. BMC Med Res Methodol. 2020; 20(1):79. PMC: 7147059. DOI: 10.1186/s12874-020-00959-3. View

de Souza-Talarico J, de Carvalho A, Brucki S, Nitrini R, Ferretti-Rebustini R . Dementia and Cognitive Impairment Prevalence and Associated Factors in Indigenous Populations: A Systematic Review. Alzheimer Dis Assoc Disord. 2016; 30(3):281-7. DOI: 10.1097/WAD.0000000000000140. View

Rosenberg R, RICHTER R, Risser R, Taubman K, Ebalo E, Posey J . Genetic factors for the development of Alzheimer disease in the Cherokee Indian. Arch Neurol. 1996; 53(10):997-1000. DOI: 10.1001/archneur.1996.00550100071017. View

Suchy-Dicey A, Shibata D, Cholerton B, Nelson L, Calhoun D, Ali T . Cognitive Correlates of MRI-defined Cerebral Vascular Injury and Atrophy in Elderly American Indians: The Strong Heart Study. J Int Neuropsychol Soc. 2019; 26(3):263-275. PMC: 7083690. DOI: 10.1017/S1355617719001073. View

Ray S, Britschgi M, Herbert C, Takeda-Uchimura Y, Boxer A, Blennow K . Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins. Nat Med. 2007; 13(11):1359-62. DOI: 10.1038/nm1653. View

10.

Moher D, Liberati A, Tetzlaff J, Altman D . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009; 151(4):264-9, W64. DOI: 10.7326/0003-4819-151-4-200908180-00135. View

11.

Walker J, Spiro G, Loewen K, Jacklin K . Alzheimer's Disease and Related Dementia in Indigenous Populations: A Systematic Review of Risk Factors. J Alzheimers Dis. 2020; 78(4):1439-1451. DOI: 10.3233/JAD-200704. View

12.

Radford K, Lavrencic L, Delbaere K, Draper B, Cumming R, Daylight G . Factors Associated with the High Prevalence of Dementia in Older Aboriginal Australians. J Alzheimers Dis. 2018; 70(s1):S75-S85. PMC: 6700619. DOI: 10.3233/JAD-180573. View

13.

Farrer L, Cupples L, Haines J, Hyman B, Kukull W, Mayeux R . Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA. 1997; 278(16):1349-56. View

14.

Li S, Guthridge S, Eswara Aratchige P, Lowe M, Wang Z, Zhao Y . Dementia prevalence and incidence among the Indigenous and non-Indigenous populations of the Northern Territory. Med J Aust. 2014; 200(8):465-9. DOI: 10.5694/mja13.11052. View

15.

Gatz M, Mack W, Chui H, Law E, Barisano G, Linda Sutherland M . Prevalence of dementia and mild cognitive impairment in indigenous Bolivian forager-horticulturalists. Alzheimers Dement. 2022; 19(1):44-55. PMC: 9458772. DOI: 10.1002/alz.12626. View

16.

Warren L, Shi Q, Young K, Borenstein A, Martiniuk A . Prevalence and incidence of dementia among indigenous populations: a systematic review. Int Psychogeriatr. 2015; 27(12):1959-70. DOI: 10.1017/S1041610215000861. View

17.

Russell S, Quigley R, Thompson F, Sagigi B, LoGiudice D, Smith K . Prevalence of dementia in the Torres Strait. Australas J Ageing. 2020; 40(2):e125-e132. DOI: 10.1111/ajag.12878. View

18.

Jervis L, Beals J, Fickenscher A, Arciniegas D . Performance on the Mini-Mental State Examination and Mattis Dementia Rating Scale among older American Indians. J Neuropsychiatry Clin Neurosci. 2007; 19(2):173-8. DOI: 10.1176/jnp.2007.19.2.173. View

19.

Huang F, Shang Y, Luo Y, Wu P, Huang X, Tan X . Lower Prevalence of Alzheimer's Disease among Tibetans: Association with Religious and Genetic Factors. J Alzheimers Dis. 2016; 50(3):659-67. DOI: 10.3233/JAD-150697. View

20.

Gavett B, Fletcher E, Harvey D, Farias S, Olichney J, Beckett L . Ethnoracial differences in brain structure change and cognitive change. Neuropsychology. 2018; 32(5):529-540. PMC: 6023745. DOI: 10.1037/neu0000452. View